New cancer drug heads to clinical trials

Tuesday, March 29, 2011 - 14:31 in Health & Medicine

A new study showed that the drug AT-406 effectively targets proteins that block normal cell death from occurring. Blocking these proteins caused tumor cells to die, while not harming normal cells. The researchers believe the drug has potential to treat multiple types of cancer.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net